The UCSF microbiologist pioneered investigations into the deadly disease starting in the late 1960s that have led to the near eradication of trachoma, a chlamydia-related eye infection.

It’s not clear why the patients with Leber hereditary optic neuropathy, a mitochondrial disorder that causes blindness, also experienced the modest benefits in their untreated eye.

Doctors in Oregon delivered the gene editing machinery behind the retina in hopes of treating an inherited form of blindness, according to the companies that developed the therapy.

The scientific community said goodbye to Sydney Brenner, Paul Greengard, Patricia Bath, and a number of other leading researchers this year.

The new policy will increase scrutiny and pressure on stem cell clinics, according to industry experts.

A trial is recruiting patients to test the gene-editing technology’s ability to treat an inherited form of blindness caused by a mutation in the CEP290 gene.

The UCLA ophthalmologist worked to combat blindness in underserved communities.

Age-related macular degeneration patients who received injections of retinal cells derived from donors’ induced pluripotent stem cells have maintained their level of eyesight for a year.

Blind rats are made to see after sheets of cells implanted into their eyes make themselves at home.

Researchers stumbled across the connection while searching for ways to reduce vision problems in people with achromatopsia.

Two studies identify a signaling pathway that contributes to the fish’s sleeplessness.

Spark Therapeutics’s Luxturna would be the first approved therapy in the U.S. that replaces or repairs a defective gene inherited from one’s parents.

By investigating the science behind “seeing” with sound, researchers hope to help blind individuals independently navigate the world.

Optometrist and eclipse-chaser Ralph Chou describes how even a partially eclipsed sun can damage the eye.

Researchers improve on a technique to use a light-stimulated small molecule to confer longer-term photosensitivity to the retinal cells of blind mice.

An experimental treatment sacrifices rod cell function to save cone cells in mice, preventing retinal degeneration, researchers report. 

A combination of visual stimulation and chemical growth promotion leads damaged retinal nerves to regenerate in mice.

Patient-derived stem cells containing a genetic mutation leading to blindness can be successfully edited using CRISPR/Cas9, researchers show.